EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Raised Creatine Kinase with Numerous Antipsychotics Responded to Clozapine

Michael Dixon, Richard Nixon, James O'Neill, Nick Venters

Psychopharmacology Bulletin · 2025

DOI: 10.64719/pb.4524 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Psychopharmacology Bulletin, 2025. Verfasst von Michael Dixon und 3 weiteren Autor:innen. Beteiligte Einrichtung: Dixon, BPharm (Hons) MFRPSI MCMHP, Lead Pharmacist for Medicines Information, Leeds and York Partnership NHS Foundation Trust, Pharmacy, Newsam Centr…. Hauptthemen laut MEDLINE: Clozapine, Antipsychotic Agents, Creatine Kinase, Schizophrenia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There is much uncertainty on continuing antipsychotics where a patient has an asymptomatic rise in creatine kinase. This case report describes a patient in his late 20s and early 30s with an established diagnosis of schizophrenia. He experienced multiple asymptomatic rises in creatine kinase (CK) when treated with numerous antipsychotics, which led to them being discontinued. Eventually, successful treatment was undertaken when clozapine was trialled. This led to improved quality of life scores when objectively measured, as well as good tolerance with no physical health sequelae. In conclusion, we recommend that clozapine is considered when other antipsychotic medications lead to elevated CK levels or neuroleptic malignant syndrome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ClozapineAntipsychotic AgentsCreatine KinaseSchizophreniaHumansMaleAdultNeuroleptic Malignant SyndromeQuality of Life

Stichwörter der Autor:innen

antipsychoticsasymptomatic creatine kinaseclozapine

Substanzen

ClozapineAntipsychotic AgentsCreatine Kinase

Autor:innen und Institutionen

  • Dixon, BPharm (Hons) MFRPSI MCMHP, Lead Pharmacist for Medicines Information, Leeds and York Partnership NHS Foundation Trust, Pharmacy, Newsam Centre, Seacroft Hospital, Leeds, UK.
  • Nixon, BM, BS, BMedSci, Speciality Doctor, Rehab and Recovery Service, Leeds and York Partnership NHS Foundation Trust, Leeds, UK.
  • O'Neill, BSc (Hons) MBChB MRCPsych, Higher Trainee in Forensic Psychiatry, South West Yorkshire Partnership NHS Foundation Trust, Leeds, UK.
  • Venters, MBChB MRCPsych MMedSc LLM, Consultant Psychiatrist, Rehab and Recovery Service, Leeds and York Partnership NHS Foundation Trust, Leeds, UK.

Zitieren

APA

Dixon, M., Nixon, R., O'Neill, J., & Venters, N. (2025). Raised Creatine Kinase with Numerous Antipsychotics Responded to Clozapine. Psychopharmacology Bulletin. https://doi.org/10.64719/pb.4524

Vancouver

Dixon M, Nixon R, O'Neill J, Venters N. Raised Creatine Kinase with Numerous Antipsychotics Responded to Clozapine. Psychopharmacology Bulletin. 2025. doi:10.64719/pb.4524

BibTeX
@article{Dixon2025,
  author = {Dixon, Michael and Nixon, Richard and O'Neill, James and Venters, Nick},
  title = {Raised Creatine Kinase with Numerous Antipsychotics Responded to Clozapine},
  journal = {Psychopharmacology Bulletin},
  year = {2025},
  doi = {10.64719/pb.4524}
}
Kostenlos starten →